[HTML][HTML] HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis

EB Chen, X Qin, K Peng, Q Li, C Tang, YC Wei… - Aging (Albany …, 2019 - ncbi.nlm.nih.gov
Gastric cancer (GC) is a common disease globally with high mortality rate. It is therefore
necessary to develop novel therapies targeting specific events in the pathogenesis of GC …

HnRNPR/CCNB1/CENPF Axis Contributes to Gastric Cancer Proliferation and Metastasis

EB Chen, X Qin, K Peng, Q Li, C Tang… - Available at SSRN …, 2019 - papers.ssrn.com
Backgroud: Gastric cancer (GC) has a high mortality rate worldwide, this calls for urgent
novel therapies targeting specific underlying oncogenic events. However, the potential …

[PDF][PDF] HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis

EB Chen, X Qin, K Peng, Q Li, C Tang, YC Wei… - …, 2019 - pdfs.semanticscholar.org
Gastric cancer (GC) is a common disease globally with high mortality rate. It is therefore
necessary to develop novel therapies targeting specific events in the pathogenesis of GC …

HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis.

EB Chen, X Qin, K Peng, Q Li, C Tang, YC Wei, S Yu… - Aging, 2019 - europepmc.org
Gastric cancer (GC) is a common disease globally with high mortality rate. It is therefore
necessary to develop novel therapies targeting specific events in the pathogenesis of GC …

HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis

EB Chen, X Qin, K Peng, Q Li, C Tang, YC Wei… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Gastric cancer (GC) is a common disease globally with high mortality rate. It is therefore
necessary to develop novel therapies targeting specific events in the pathogenesis of GC …

HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis.

EB Chen, X Qin, K Peng, Q Li, C Tang, YC Wei, S Yu… - Aging, 2019 - europepmc.org
Gastric cancer (GC) is a common disease globally with high mortality rate. It is therefore
necessary to develop novel therapies targeting specific events in the pathogenesis of GC …